58 related articles for article (PubMed ID: 33125112)
41. ASC-US diagnosis and triage.
Del Mistro A
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S2-4. PubMed ID: 17727939
[No Abstract] [Full Text] [Related]
42. [Microsatellite instability and human papilloma virus genotypes in preneoplastic and neoplastic uterine cervix lesions].
Roa S JC; Martínez S R; Montenegro S; Roa E I; Capurro V I; Ibacache S G; Melo A A
Rev Med Chil; 2007 Jan; 135(1):37-44. PubMed ID: 17369982
[TBL] [Abstract][Full Text] [Related]
43. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
44. A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence.
Walker H; Burrell M; Flatley J; Powers H
Bioanalysis; 2017 Apr; 9(8):601-608. PubMed ID: 28508693
[TBL] [Abstract][Full Text] [Related]
45. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
Pereira IOA; Silva NNT; Lima AA; da Silva GN
Environ Mol Mutagen; 2024; 65(3-4):143-152. PubMed ID: 38523463
[TBL] [Abstract][Full Text] [Related]
46. Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review).
Sheng J; Xiang Y; Shang L; He Q
Oncol Rep; 2020 Dec; 44(6):2397-2405. PubMed ID: 33125112
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.
Mersakova S; Nachajova M; Szepe P; Kasajova PS; Halasova E
Tumour Biol; 2016 Jan; 37(1):23-7. PubMed ID: 26459314
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
Cuschieri K; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2536-45. PubMed ID: 18842994
[TBL] [Abstract][Full Text] [Related]
49. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
50. The natural history of cervical HPV infection: unresolved issues.
Woodman CB; Collins SI; Young LS
Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
[TBL] [Abstract][Full Text] [Related]
51. Cervical Carcinoma: Oncobiology and Biomarkers.
Volkova LV; Pashov AI; Omelchuk NN
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]